Sichuan Kelun-Biotech Biopharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Sichuan Kelun-Biotech Biopharmaceutical has a total shareholder equity of CN¥3.2B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥3.8B and CN¥625.5M respectively.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥2.89b |
| Equity | CN¥3.21b |
| Total liabilities | CN¥625.51m |
| Total assets | CN¥3.83b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 6990's short term assets (CN¥3.2B) exceed its short term liabilities (CN¥553.8M).
Long Term Liabilities: 6990's short term assets (CN¥3.2B) exceed its long term liabilities (CN¥71.7M).
Debt to Equity History and Analysis
Debt Level: 6990 is debt free.
Reducing Debt: 6990 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 6990 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 6990 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.